This collaborative public-private research and development program aims to contribute to the management and prevention of microbiological and virological contamination risks, for better protection and quality of indoor air in confined spaces.

Alongside their partners VirexpR, Conidia-Coniphy and IMéBIO, Virnext and the VirPath laboratory are committed to develop an ambitious technology offering that is unique in Europe. The aim of the GESPPAIR consortium is also to bring together other industrial and academic players to create in the Auvergne-Rhône-Alpes region an internationally-targeted sector of excellence in the management and prevention of contamination risks from emerging and re-emerging infectious pathogens in confined environments.

Press release :